eamdacademy.org-XSsc-1790348998-g585765347 1790348998 Eurasian Academy of Medicine and Dentistry info@eamdacademy.org Eurasian Academy of Medicine and Dentistry Journal of Applied Pharmaceutical Technologies and Systems J Appl Pharm Technol Syst 3149-9589 2026 5 2 Omar Khalid Sara Nadeem Bilal Farooq Hina Saeed 2026 10.68159/g585765347 https://eamdacademy.org/pub/journal/3/article/g585765347 Agrahari V, Hiremath P. Challenges associated and approaches for successful translation of nanomedicines into commercial products. Nanomedicine. 2017;12(8):819-23. Agrahari V, Agrahari V. Facilitating the translation of nanomedicines to a clinical product: challenges and opportunities. Drug Discov Today. 2018;23(5):974-91. Hua S, De Matos MB, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Front Pharmacol. 2018;9:790. Coty JB, Vauthier C. Characterization of nanomedicines: a reflection on a field under construction needed for clinical translation success. J Control Release. 2018;275:254-68. Leroux JC. The novelty bubble. J Control Release. 2018;278:140. Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9(1):1410. Tracy T, Wu L, Liu X, Cheng S, Li X. 3D printing: Innovative solutions for patients and pharmaceutical industry. Int J Pharm. 2023;631:122480. Li W, Tang J, Lee D, Tice TR, Schwendeman SP, Prausnitz MR. Clinical translation of long-acting drug delivery formulations. Nat Rev Mater. 2022;7(5):406-20. He H, Liu L, Morin EE, Liu M, Schwendeman A. Survey of clinical translation of cancer nanomedicines—lessons learned from successes and failures. Acc Chem Res. 2019;52(9):2445-61. Metselaar JM, Lammers T. Challenges in nanomedicine clinical translation. Drug Deliv Transl Res. 2020;10(3):721-5. Witzigmann D, Hak S, van der Meel R. Translating nanomedicines: thinking beyond materials? A young investigator’s reply to ‘The Novelty Bubble.’ J Control Release. 2018;290:138-40. Đorđević S, Gonzalez MM, Conejos-Sánchez I, Carreira B, Pozzi S, Acúrcio RC, et al. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res. 2022;12(3):500-25. Younis MA, Tawfeek HM, Abdellatif AA, Abdel-Aleem JA, Harashima H. Clinical translation of nanomedicines: Challenges, opportunities, and keys. Adv Drug Deliv Rev. 2022;181:114083. Rawal M, Singh A, Amiji MM. Quality-by-Design Concepts to Improve Nanotechnology-Based Drug Development: Rawal, Singh and Amiji. Pharm Res. 2019;36(11):153. Holm R, Lee RW, Glassco J, DiFranco N, Bao Q, Burgess DJ, et al. Long-acting injectable aqueous suspensions—summary from an AAPS Workshop. AAPS J. 2023;25(3):49. Crommelin DJ, van Hoogevest P, Storm G. The role of liposomes in clinical nanomedicine development. What now? Now what? J Control Release. 2020;318:256-63. Dri DA, Rinaldi F, Carafa M, Marianecci C. Nanomedicines and nanocarriers in clinical trials: surfing through regulatory requirements and physico-chemical critical quality attributes. Drug Deliv Transl Res. 2023;13(3):757-69. Ma Z, Zhang H, Wang Y, Tang X. Development and evaluation of intramuscularly administered nano/microcrystal suspension. Expert Opin Drug Deliv. 2019;16(4):347-61. Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G. Nanotechnology approaches for global infectious diseases. Nat Nanotechnol. 2021;16(4):369-84. Joyce P, Allen CJ, Alonso MJ, Ashford M, Bradbury MS, Germain M, et al. A translational framework to DELIVER nanomedicines to the clinic. Nat Nanotechnol. 2024;19(11):1597-611. Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101-24. Gao J, Karp JM, Langer R, Joshi N. The future of drug delivery. Chem Mater. 2023;35(2):359-63. Correia A, Cordeiro M, Mendes M, Marques M, Mascarenhas-Melo F, Vitorino C. Additive manufacturing of microneedles: A quality by design approach to clinical translation. Int J Pharm. 2025;126399. Gioumouxouzis CI, Eleftheriadis GK, Kyriakidis AS, Karavasili C. Translation of pharmaceutical 3D printing to clinical point-of-care and industrial manufacturing. Drug Deliv Transl Res. 2026;1-4. Stucchi F, Li M, Castellano G, Cellesi F. Regulatory framework for polymer-based nanotherapeutics in clinical translation. Front Bioeng Biotechnol. 2026;14:1735885.